Edition:
United States

Healthcare

Merck's Keytruda fails late-stage study in liver cancer patients

Feb 19 Merck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a type of liver cancer.

Stock Quote, 4:33pm EST

UPDATE 3-Allergan should explore selling itself - Appaloosa's Tepper

Feb 19 Billionaire hedge fund manager David Tepper stepped up pressure on Allergan Plc, saying on Tuesday the drugmaker should consider selling itself if management is unable to turn around recent lagging performance.

UPDATE 1-Honeywell-Pratt venture protests GE's Army helicopter contract

Feb 19 A joint venture of Honeywell International Inc and Pratt & Whitney on Tuesday protested the U.S. Army's decision to award General Electric Co a $517 million contract for new Black Hawk and Apache helicopter engines.

Stock Quote, Industrials, 2:34pm EST

Honeywell-Pratt venture protests U.S. Army's contract to GE

Feb 19 A joint venture of Honeywell International Inc and Pratt & Whitney on Tuesday protested the U.S. Army's decision to award General Electric Co a contract for new Black Hawk and Apache helicopter engines.

Financials, Stock Quote 1:36pm EST

UPDATE 1-U.S. top court rejects bid to block Indivior opioid drug copycat

WASHINGTON, Feb 19 The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm's lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy's Laboratories .

Stock Quote 11:35am EST
Healthcare
Johnson & Johnson $135.69 -0.51%
UnitedHealth Group Inc $270.41 -0.27%
Pfizer Inc $42.60 +0.47%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.